CCO Infectious Disease Podcast

Hepatitis Delta in Focus: Episode 4 of Answering the Questions on Screening, Diagnosis, and Treatment

Episode Summary

In this podcast episode, listen to expert faculty perspectives on HDV management, including screening, staging liver disease, approach to treatment—such as whom to treat and for how long—and considerations for combination therapy.

Episode Notes

In this episode, Tarik Asselah, MD, PhD, and Ira Jacobson, MD, provide expert insight on HDV screening, diagnosis, and management, including:

• Approach to screening
• Barriers to screening (eg, test availability)
• Disease progression and complications
• Differentiating between coinfection and superinfection
• Approach to treatment (eg, whom to treat and when, treatment options, considerations for combination therapy)
• Management of patients with decompensated cirrhosis
• Surrogate markers to measure treatment success
• Role of correcting thrombocytopenia before initiating therapy

Faculty:

Tarik Asselah, MD, PhD
Professor of Medicine 
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France

Ira Jacobson, MD
Professor of Medicine
NYU School of Medicine
Director of Hepatology
Division of Gastroenterology and Hepatology
NYU Langone Health
New York, New York

Link to full program: https://bit.ly/3yp1Lxf